Randomized controlled trials among survivors of obesity-related cancers have shown favorable insulin and insulin-like-growth factor (IGF), inflammation, and immune system responses to enhanced exercise [33–36]. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.